c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

BACKGROUND: KIT inhibitors, such as toceranib (TOC), and vinblastine (VBL) have not been prospectively compared in the treatment of macroscopic mast cell tumors (MCTs). Also, it is unknown whether VBL or TOC is superior for treating MCT without c‐kit mutations. HYPOTHESIS/OBJECTIVES: To determine th...

Full description

Saved in:
Bibliographic Details
Published in:J Vet Intern Med
Main Authors: Weishaar, K.M., Ehrhart, E.J., Avery, A.C., Charles, J.B., Elmslie, R.E., Vail, D.M., London, C.A., Clifford, C.A., Eickhoff, J.C., Thamm, D.H.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2017
Subjects:
SMALL ANIMAL
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5787208/
https://ncbi.nlm.nih.gov/pubmed/29194765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.14889
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items